These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 27344782)

  • 21. [Interest of the radiotherapy-hormonotherapy association in the treatment of the high-risk prostate cancer].
    Bolla M; Fourneret P; Descotes JL
    Bull Cancer; 2008 Dec; 95(12):1213-8. PubMed ID: 19091656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose escalated external beam radiotherapy versus neoadjuvant androgen deprivation therapy and conventional dose external beam radiotherapy for clinically localized prostate cancer: do we need both?
    Roach M
    Strahlenther Onkol; 2007 Dec; 183 Spec No 2():26-8. PubMed ID: 18167004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A dose distribution overlay technique for image guidance during prostate radiotherapy.
    Smyth G; McCallum HM; Lambert EL; Lawrence GP
    Br J Radiol; 2008 Nov; 81(971):890-6. PubMed ID: 18824502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The changing costs of radiation treatment for early prostate cancer in Ontario: a comparison between conventional and conformal external beam radiotherapy.
    Poon I; Pintilie M; Potvin M; McGowan T
    Can J Urol; 2004 Feb; 11(1):2125-32. PubMed ID: 15003151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [High dose rate prostate brachytherapy].
    Nickers P; Blanchard P; Hannoun-Lévi JM; Bossi A; Chapet O; Guérif S
    Cancer Radiother; 2013 Apr; 17(2):118-24. PubMed ID: 23578898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A call for more with a desire for less: pelvic radiotherapy with androgen deprivation in the treatment of prostate cancer.
    Pollack A
    J Clin Oncol; 2003 May; 21(10):1899-901. PubMed ID: 12743140
    [No Abstract]   [Full Text] [Related]  

  • 27. The ethics of hypofractionation for prostate cancer.
    Lee WR
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):969-70. PubMed ID: 19251081
    [No Abstract]   [Full Text] [Related]  

  • 28. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Choosing wisely: the American Society for Radiation Oncology's top 5 list.
    Hahn C; Kavanagh B; Bhatnagar A; Jacobson G; Lutz S; Patton C; Potters L; Steinberg M
    Pract Radiat Oncol; 2014; 4(6):349-55. PubMed ID: 25407853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Combination of external irradiation and androgen suppression for prostate cancer: facts and questions].
    Bolla M; Fourneret P; Beneyton V; Tessier A; Jover F; Verry C
    Cancer Radiother; 2010 Oct; 14(6-7):510-4. PubMed ID: 20728391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Trends and future of external radiotherapy for prostate cancer].
    Nakamura K; Sasaki T
    Nihon Rinsho; 2011 Jun; 69 Suppl 5():408-11. PubMed ID: 22208012
    [No Abstract]   [Full Text] [Related]  

  • 32. Intensity modulated radiation therapy (IMRT): a new promising technology in radiation oncology.
    Teh BS; Woo SY; Butler EB
    Oncologist; 1999; 4(6):433-42. PubMed ID: 10631687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Royal College of Radiologists' Clinical Oncology Information Network. British Association of Urological Surgeons. Guidelines on the management of prostate cancer.
    Clin Oncol (R Coll Radiol); 1999; 11(2):S53-88. PubMed ID: 10378644
    [No Abstract]   [Full Text] [Related]  

  • 34. Quality of life of men treated with brachytherapies for prostate cancer.
    Lev EL; Eller LS; Gejerman G; Lane P; Owen SV; White M; Nganga N
    Health Qual Life Outcomes; 2004 Jun; 2():28. PubMed ID: 15198803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose escalation by proton irradiation for adenocarcinoma of the prostate.
    Cox JD
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):265-6. PubMed ID: 7721627
    [No Abstract]   [Full Text] [Related]  

  • 36. Radiation Therapy Oncology Group. Research Plan 2002-2006. Genitourinary Cancer Committee.
    Sandler H; Shipley WU; Gomella L; Pienta K; Bard RH; Bruner D; Clark R; DeSilvio M; Gaspar L; Gillin M; Grignon D; Hammond E; Hanks G; Heydon KH; Kaufman DS; Lee WR; Michalski J; Mydlo J; Pisansky T; Pollack A; Porterfield H; Rifkin M; Roach M; Sanda M; True L; Vijayakumar S; Winter KA; Zeitman A;
    Int J Radiat Oncol Biol Phys; 2001; 51(3 Suppl 2):28-38. PubMed ID: 11641012
    [No Abstract]   [Full Text] [Related]  

  • 37. Why "radiation oncology".
    Belka C; Camphausen KA
    Radiat Oncol; 2006 Feb; 1():1. PubMed ID: 16722574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical trials and radiation oncology technologies.
    Michalski JM; Bosch WR; Purdy JA
    Oncology (Williston Park); 2009 Apr; 23(4):386, 389. PubMed ID: 19476270
    [No Abstract]   [Full Text] [Related]  

  • 39. Assessing the impact of an alternative biochemical failure definition on radiation dose response for high-risk prostate cancer treated with external beam radiotherapy.
    Cheung R; Tucker SL; Lee AL; Dong L; Kamat A; Pisters L; Kuban DA
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):14-9. PubMed ID: 15629589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ultrahpyofractionated radiotherapy for prostate cancer-a new standard?].
    Höcht S; Böhmer D; Wiegel T; Ganswindt U;
    Urologie; 2023 Mar; 62(3):299-301. PubMed ID: 36853507
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.